Skip to main content
Top
Published in: Clinical Research in Cardiology 7/2021

Open Access 01-07-2021 | Anticoagulant | Original Paper

Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study

Authors: Pietro Ameri, Riccardo M. Inciardi, Mattia Di Pasquale, Piergiuseppe Agostoni, Antonio Bellasi, Rita Camporotondo, Claudia Canale, Valentina Carubelli, Stefano Carugo, Francesco Catagnano, Giambattista Danzi, Laura Dalla Vecchia, Stefano Giovinazzo, Massimiliano Gnecchi, Marco Guazzi, Anita Iorio, Maria Teresa La Rovere, Sergio Leonardi, Gloria Maccagni, Massimo Mapelli, Davide Margonato, Marco Merlo, Luca Monzo, Andrea Mortara, Vincenzo Nuzzi, Massimo Piepoli, Italo Porto, Andrea Pozzi, Giovanni Provenzale, Filippo Sarullo, Gianfranco Sinagra, Chiara Tedino, Daniela Tomasoni, Maurizio Volterrani, Gregorio Zaccone, Carlo Mario Lombardi, Michele Senni, Marco Metra

Published in: Clinical Research in Cardiology | Issue 7/2021

Login to get access

Abstract

Background

Pulmonary embolism (PE) has been described in coronavirus disease 2019 (COVID-19) critically ill patients, but the evidence from more heterogeneous cohorts is limited.

Methods

Data were retrospectively obtained from consecutive COVID-19 patients admitted to 13 Cardiology Units in Italy, from March 1st to April 9th, 2020, and followed until in-hospital death, discharge, or April 23rd, 2020. The association of baseline variables with computed tomography-confirmed PE was investigated by Cox hazards regression analysis. The relationship between d-dimer levels and PE incidence was evaluated using restricted cubic splines models.

Results

The study included 689 patients (67.3 ± 13.2 year-old, 69.4% males), of whom 43.6% were non-invasively ventilated and 15.8% invasively. 52 (7.5%) had PE over 15 (9–24) days of follow-up. Compared with those without PE, these subjects had younger age, higher BMI, less often heart failure and chronic kidney disease, more severe cardio-pulmonary involvement, and higher admission d-dimer [4344 (1099–15,118) vs. 818.5 (417–1460) ng/mL, p < 0.001]. They also received more frequently darunavir/ritonavir, tocilizumab and ventilation support. Furthermore, they faced more bleeding episodes requiring transfusion (15.6% vs. 5.1%, p < 0.001) and non-significantly higher in-hospital mortality (34.6% vs. 22.9%, p = 0.06). In multivariate regression, only d-dimer was associated with PE (HR 1.72, 95% CI 1.13–2.62; p = 0.01). The relation between d-dimer concentrations and PE incidence was linear, without inflection point. Only two subjects had a baseline d-dimer < 500 ng/mL.

Conclusions

PE occurs in a sizable proportion of hospitalized COVID-19 patients. The implications of bleeding events and the role of d-dimer in this population need to be clarified.

Graphic abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513CrossRef Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513CrossRef
2.
go back to reference Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323:2052–2059CrossRef Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323:2052–2059CrossRef
6.
go back to reference Edler C, Schröder AS, Aepfelbacher M et al (2020) Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med 134:1275–1284CrossRef Edler C, Schröder AS, Aepfelbacher M et al (2020) Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int J Legal Med 134:1275–1284CrossRef
8.
go back to reference Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148–150CrossRef Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 191:148–150CrossRef
9.
go back to reference Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089–1098CrossRef Helms J, Tacquard C, Severac F et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46(6):1089–1098CrossRef
10.
go back to reference Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18:1421–1424CrossRef Cui S, Chen S, Li X, Liu S, Wang F (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 18:1421–1424CrossRef
11.
go back to reference Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM et al (2020) Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res 192:113–115CrossRef Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM et al (2020) Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res 192:113–115CrossRef
12.
go back to reference Lodigiani C, Iapichino G, Carenzo L et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan. Italy Thromb Res 191:9–14CrossRef Lodigiani C, Iapichino G, Carenzo L et al (2020) Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan. Italy Thromb Res 191:9–14CrossRef
14.
go back to reference Righini M, Van Es J, Exter PLD et al (2014) Age-adjusted d-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE Study. JAMA 311:1117–1124CrossRef Righini M, Van Es J, Exter PLD et al (2014) Age-adjusted d-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE Study. JAMA 311:1117–1124CrossRef
15.
go back to reference Al-Ani F, Chehade S, Lazo-Langner A (2020) Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 192:152–160CrossRef Al-Ani F, Chehade S, Lazo-Langner A (2020) Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res 192:152–160CrossRef
19.
go back to reference Thachil J, Tang N, Gando S et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18:1023–1026CrossRef Thachil J, Tang N, Gando S et al (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 18:1023–1026CrossRef
22.
go back to reference Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135:2033–2040CrossRef Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135:2033–2040CrossRef
23.
go back to reference Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with Novel Coronavirus pneumonia. J Thromb Haemost 18:844–847CrossRef Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with Novel Coronavirus pneumonia. J Thromb Haemost 18:844–847CrossRef
26.
go back to reference Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603CrossRef Konstantinides SV, Meyer G, Becattini C et al (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603CrossRef
29.
Metadata
Title
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study
Authors
Pietro Ameri
Riccardo M. Inciardi
Mattia Di Pasquale
Piergiuseppe Agostoni
Antonio Bellasi
Rita Camporotondo
Claudia Canale
Valentina Carubelli
Stefano Carugo
Francesco Catagnano
Giambattista Danzi
Laura Dalla Vecchia
Stefano Giovinazzo
Massimiliano Gnecchi
Marco Guazzi
Anita Iorio
Maria Teresa La Rovere
Sergio Leonardi
Gloria Maccagni
Massimo Mapelli
Davide Margonato
Marco Merlo
Luca Monzo
Andrea Mortara
Vincenzo Nuzzi
Massimo Piepoli
Italo Porto
Andrea Pozzi
Giovanni Provenzale
Filippo Sarullo
Gianfranco Sinagra
Chiara Tedino
Daniela Tomasoni
Maurizio Volterrani
Gregorio Zaccone
Carlo Mario Lombardi
Michele Senni
Marco Metra
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 7/2021
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-020-01766-y

Other articles of this Issue 7/2021

Clinical Research in Cardiology 7/2021 Go to the issue